Selective apheresis - Time for a change

International Journal of Artificial Organs

Volumn 24, Issue 1, 2001, Pages 4-7

  Matic, G ^a   Winkler, R E ^a   Tiess, M ^a   Ramlow, W ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8 ANTIBODY; COLLAGEN TYPE 4; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; HLA ANTIBODY; IMMUNOGLOBULIN ANTIBODY; PEPTIDE; POLYVINYL DERIVATIVE; PROTEIN A; PROTEINASE INHIBITOR; SILICON DIOXIDE;

ADSORPTION; ANTIGEN ANTIBODY COMPLEX; APHERESIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOMEDICAL TECHNOLOGY ASSESSMENT; CARDIOMYOPATHY; EDITORIAL; EXTRACORPOREAL CIRCULATION; FRACTIONATION; GUILLAIN BARRE SYNDROME; HEART TRANSPLANTATION; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANE FILTER; MYASTHENIA GRAVIS; PLASMAPHERESIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RHEUMATOID ARTHRITIS;

EID: 0035114551     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880102400102     Document Type: Editorial

References (30)

1. Therapeutic apheresis in the United States: Current indications and directions
2. Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis
3. Effect of plasma exchange on circulating immune complexes and antibody formation in patients treated with cyclophosphamide and prednisone
4. Plasmapheresis in the management of acute systemic lupus erythematosus?
5. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
6. Thrombotic thrombocytopenic purpura treatment in year 2000
7. Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: Evaluation of 602 sessions of extracorporeal immunoadsorption
8. Extracorporeal removal of circulating immune complexes: From non-selective to patient-specific
9. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis
10. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide
11. Present status of apheresis technologies, part 3: Adsorbent
12. Plasmapheresis and immunoadsorption: Different techniques and their current role in medical therapy
13. Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease
14. Management of immune-mediate and paraproteinemic diseases by membrane plasma separation and cascade filtration
15. Membrane apheresis technology: Historical perspective and new trends toward bioincompatible systems
16. Present status of apheresis technologies: Part 2. Membrane plasma functionator
17. Cryofiltration apheresis in the United States
18. Clinical evaluation of a staphylococcal protein A immunoadsorption system in the treatment of myasthenia gravis patients
19. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation
20. Tolerance induction using the Malmo treatment model 1982-1995
21. Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study
22. Protein A immunoadsorption treatment in hematology: An overview
23. A phase II treatment of extracorporeal plasma immunoadsorption of patient plasma with Prosorba columns for treating metastatic breast cancer
24. Protein A immunoadsorption in the treatment of malignant disease
25. The Prosorba column for treatment of refractory rheumatoid arthritis: A randomized, double-blind, sham-controlled trial
26. Immunoadsorption of immunoglobulins alters intracytoplasmic type 1 and type 2 T cell cytokine production in patients with refractory autoimmune diseases
27. C1q: A multifunctional ligand for a new immunoadsorption treatment
28. Safety and kinetics of the C1q-adsorber
29. Agonist-like beta-adrenoceptor antibodies in heart failure
30. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy